ADNI | Publications

Filter results by:

3393 Total Publications

Early Prediction of Alzheimer’s Disease Using Null Longitudinal Model-Based Classifiers
G. Gavidia-Bovadilla, S. Kanaan-Izquierdo, M. Mataró-Serrat, A. Perera-Lluna and A. s. D. N. Initiative
2017; Journal PloS one; vol. 12; no. 1; pp. e0168011; doi:10.1371/journal.pone.0168011

Managing money matters: Managing finances is associated with functional independence in MCI
C. Berezuk, J. Ramirez, S. E. Black and K. K. Zakzanis
2017; Journal International Journal of Geriatric Psychiatry; vol. 33; no. 3; pp. 517-522; doi:10.1002/gps.4817

Reference region selection and the association between the rate of amyloid accumulation over time and the baseline amyloid burden
J. Blautzik, M. Brendel, J. Sauerbeck, S. Kotz, F. Scheiwein, P. Bartenstein, J. Seibyl, A. Rominger and I. Alzheimer's Disease Neuroimaging
2017; Journal Eur J Nucl Med Mol Imaging; vol. 44; no. 8; pp. 1364-1374; doi:10.1007/s00259-017-3666-8

Serum SHBG Levels are not Associated with Longitudinal Cognitive Decline in Mild Cognitive Impairment
K. A. Lin, C. Rundel, P. M. Doraiswamy and I. Alzheimer's Disease Neuroimaging
2017; Journal J Alzheimers Dis; vol. 55; no. 3; pp. 1123-1130; doi:10.3233/JAD-160513

Associations between APOE genotype and cerebral small-vessel disease: a longitudinal study
X. Luo, Y. Jiaerken, X. Yu, P. Huang, T. Qiu, Y. Jia, K. Li, X. Xu, Z. Shen, X. Guan, J. Zhou, M. Zhang and F. Adni
PMCID:5546495 ; 2017; Journal Oncotarget; vol. 8; no. 27; pp. 44477-44489; doi:10.18632/oncotarget.17724

Hypertension is associated with worse cognitive function and hippocampal hypometabolism in Alzheimer's disease
I. Moonga, F. Niccolini, H. Wilson, G. Pagano and M. Politis
2017; Journal European Journal of Neurology; vol. 24; no. 9; pp. 1173-1182; doi:10.1111/ene.13374

Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease
K. P. Ng, T. A. Pascoal, S. Mathotaarachchi, C. O. Chung, A. L. Benedet, M. Shin, M. S. Kang, X. Li, M. Ba, N. Kandiah, P. Rosa-Neto, S. Gauthier and I. Alzheimer's Disease Neuroimaging
PMCID:5419982 ; 2017; Journal Neurology; vol. 88; no. 19; pp. 1814-1821; doi:10.1212/WNL.0000000000003916

FGWAS: Functional genome wide association analysis
C. Huang, P. Thompson, Y. Wang, Y. Yu, J. Zhang, D. Kong, R. R. Colen, R. C. Knickmeyer, H. Zhu and I. Alzheimer's Disease Neuroimaging
2017; Journal Neuroimage; vol. 159; pp. 107-121; doi:10.1016/j.neuroimage.2017.07.030

Sex differences in the association between AD biomarkers and cognitive decline
M. E. I. Koran, M. Wagener, T. J. Hohman and I. Alzheimer's Neuroimaging
PMCID:4972701 ; 2017; Journal Brain Imaging Behav; vol. 11; no. 1; pp. 205-213; doi:10.1007/s11682-016-9523-8

Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score
R. S. Desikan, C. C. Fan, Y. Wang, A. J. Schork, H. J. Cabral, L. A. Cupples, W. K. Thompson, L. Besser, W. A. Kukull, D. Holland, C. H. Chen, J. B. Brewer, D. S. Karow, K. Kauppi, A. Witoelar, C. M. Karch, L. W. Bonham, J. S. Yokoyama, H. J. Rosen, B. L. Miller, W. P. Dillon, D. M. Wilson, C. P. Hess, M. Pericak-Vance, J. L. Haines, L. A. Farrer, R. Mayeux, J. Hardy, A. M. Goate, B. T. Hyman, G. D. Schellenberg, L. K. McEvoy, O. A. Andreassen and A. M. Dale
PMCID:5360219 ; 2017; Journal PLoS Med; vol. 14; no. 3; pp. e1002258; doi:10.1371/journal.pmed.1002258